Although Aracava et al. considered antagonism of memantine on α7 nAChR as a negative phenomenon in Alzheimer’s disease treatment [80], the antagonism is considered to be beneficial in Alzheimer’s disease treatment according to other scientists [81]. This evidence concerns the gene CHRNA7 and early-onset autosomal dominant Alzheimer disease.